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Summary
The genetic trait that allows intestinal lactase to persist into adulthood in some 35% of humans worldwide operates at
the level of transcription, the effect being caused by cis-acting nucleotide changes upstream of the lactase gene (LCT).
A single nucleotide substitution, -13910 C>T, the first causal variant to be identified, accounts for lactase persistence
over most of Europe. Located in a region shown to have enhancer function in vitro, it causes increased activity of the
LCT promoter in Caco-2 cells, and altered transcription factor binding. Three other variants in close proximity, -13907
C>G, -13915 T>C and -14010 G>C, were later shown to behave in a similar manner. Here, we study four further
candidate functional variants. Two, -14009 T>G and -14011 C>T, adjacent to the well-studied -14010 G>C variant,
also have a clear effect on promoter activity upregulation as assessed by transfection assays, but notably are involved in
different molecular interactions. The results for the two other variants (-14028 T>C, -13779 G>C) were suggestive of
function, -14028∗C showing a clear change in transcription factor binding, but no obvious effect in transfections, while
-13779∗G showed greater effect in transfections but less on transcription factor binding. Each of the four variants arose
on independent haplotypic backgrounds with different geographic distribution.
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Introduction
The expression of the intestinal enzyme lactase, which is criti-
cal for themajority of Eutherianmammals during the suckling
period, is generally downregulated after weaning, but persists
into adult life in some humans. This trait, known as lactase
persistence (LP, MIM 223100), is carried by some 35% of
the world’s population and is notably more frequent in pop-
ulations with a long history of pastoralism and dairy farming
(Ingram et al., 2009a).
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It has been shown that the differential expression of human
lactase (lactase–phlorizin hydrolase, LPH, EC 3.2.1.108) in
adults is regulated at the level of transcription and the effect
is cis-acting to the lactase gene (LCT) (Ho et al., 1982; Flatz,
1984; Wang et al., 1995; Kuokkanen et al., 2003. A single
nucleotide substitution, -13910∗T (rs4988235), about 14 kb
upstream of the LCT transcriptional start site, in intron 13 of
the neighbouring MinichromosomeMaintenance 6 (MCM6)
gene was the first causal variant to be identified (Enattah et al.,
2002) and accounts for LP over most of Europe (Enattah
et al., 2002; Kuokkanen et al., 2003; Poulter et al., 2003;
Enattah et al., 2007). It is located in a region shown to have
enhancer function in vitro (Olds & Sibley, 2003; Troelsen et al.,
2003; Lewinsky et al., 2005) and compared to the ancestral
variant, the presence of -13910∗T results in about twofold
increased enhancer activation of the LCT promoter in human
intestinal–derived Caco-2 cells, as well as altered transcription
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factor binding (Troelsen et al., 2003; Lewinsky et al., 2005;
Ingram et al., 2007; Olds et al., 2011), indicating that this
variant accounts for LP in its carriers, and this functional
effect is supported by in vivo studies in mice (Fang et al.,
2012).
During the course of screening the LCT enhancer se-
quence for novel variation, we and other investigators found
a number of other variants clustering in close proximity to
each other. In the first studies, three further functional al-
leles were identified in Middle Eastern and African popula-
tions: -13915∗G (rs41380347), -13907∗G (rs41525747) and
-14010∗C (rs145946881). These also showed increase re-
porter gene expression compared to the ancestral variants
and/or differences in protein-DNA binding affinity (Ingram
et al., 2007; Tishkoff et al., 2007; Enattah et al., 2008, Jensen
et al., 2011, Olds et al., 2011).
Several other variants have been found in the enhancer re-
gion (e.g. Ingram, 2008; Ingram et al., 2009b; Jones et al.,
2013; Baffour-Awuah et al., 2015). Some have been shown
not to be positively associated with lactose digester status [e.g.
-13913 T>C ( Jones et al., 2013)], while others were candi-
date LP variants. Four of these allelic variants were chosen for
in vitro functional tests and the results are reported here.
-14009∗G (rs869051967) was selected because it was
strongly associated with digester status ( Jones et al., 2013),
and -14011∗T (rs4988233) (Lember et al., 2006; Friedrich
et al., 2012; Gallego Romero et al., 2012; Jones et al., 2013),
although too rare to test for association, is also located imme-
diately adjacent to the known functional variant -14010∗C.
-13779∗G (rs527991977) was of interest because it was found
to be relatively common in some groups in India, in the
milk drinking Toda, for example, though it was also found in
hunter-gatherers (Gallego Romero et al., 2012). -14028∗C
(rs759157971) had previously been found as the only LCT
enhancer allele identified in the second highest expressing
transcript of a homozygous lactase persistent person (Poulter
et al., 2003; Ingram, 2008). Here, we report functional anal-
ysis for these four derived variant alleles in comparison with
the ancestral sequence using cell culture transfection and gel
shift experiments. We tested both undifferentiated and differ-
entiated Caco-2 cells in this study, since it is well known that
intestinal hydrolyses increase in their expression in the course
of differentiation of this cell line, and that there are alterations
in expression of the associated transcription factors (Chantret
et al., 1988; Boyd et al., 2010). Preliminary results for the
effect of -14009∗G in transfection experiments have been re-
ported recently by our group ( Jones et al., 2013) but here the
function of this site is investigated in much more detail.
We show that the three adjacent variant alleles -14009∗G,
-14010∗C and -14011∗T have similar and clear effects on
upregulation of promoter function, as assessed by transfec-
tion, but are each involved in different molecular interactions.
The results obtained for -13779∗G and -14028∗C were also
suggestive of function but were less conclusive.
Materials and Methods
Cell Culture
Human Caco-2 cells were cultured in Dulbecco’s modi-
fied Eagle’s medium, supplemented by 100 U/ml penicillin,
100μg/ml streptomycin and 10% foetal calf serum. Cells were
kept in a humid environment at 37°C and 5% CO2 and split
at 80% confluence (after 3–4 days), and left to differentiate for
13 days after seeding, before preparation of nuclear extracts,
as described elsewhere (Ausubel et al., 2002; Troelsen et al.,
2003).
For gel shift assays, sense and antisense oligonucleotides
(Table S1) were annealed and radioactively 5′ labelled us-
ing T4 Polynucleotide Kinase (Fermentas, Thermo Fisher,
Copenhagen, Denmark) and 25–35 μCi [γ 32P]ATP (Perkin
Elmer, Skovlunde, Denmark). The probes were purified using
MicroSpin G-25 Columns (Illustra, GE Healthcare, Brondby,
Denmark).
Each protein/DNA binding reaction contained 4.5–9.0 μg
differentiated Caco-2 nuclear extract, 4 μl dialysis buffer
(20 mM HEPES [pH 7.9], 20% glycerol, 1.5 mM MgCl2,
100 mM KCl, 0.2 mM EDTA, 0.5 mM DTT) and 10 μl gel
shift buffer (25 mM Tris-HCl [pH 7.8], 5 mMMgCl2, 6 mM
KCl, 0.5 mM EDTA, 1 mMDTT, 1 μl/ml protease inhibitor
cocktail [Sigma-Aldrich, Brondby, Denmark], 5% Ficoll [PM
400], 2.5% glycerol). A total of 0.25 μg poly-dI-dC (Sigma-
Aldrich, Brondby, Denmark) and 2.5 pmol of unlabelled un-
specific oligonucleotides were added to minimize nonspecific
DNA binding, though some nonspecific binding is unavoid-
able. Bands were classified as specific when they were con-
sistently present in several experiments and were reduced or
removed when competed with specific unlabelled oligonu-
cleotides and not with unspecific unlabelled oligonucleotides.
To identify proteins forming the DNA–protein complexes,
specific antibodies were used to obtain evidence of change in
electrophoretic pattern (decrease in electrophoretic mobility,
known as supershift, or reduction of band intensity). A total
of 1–2 μl of antibodies to Cdx-2 (BioGenex, Brondby, Den-
mark), Oct-1, (Hepatic Nuclear Factor) HNF-1α, HNF-4α,
Ets-1/2 or Ets-1 (all Santa Cruz Biotechnology, Aarhus, Den-
mark) were used. As a second approach competition assays
were carried out, for which 2.5 pmol of the unlabelled an-
nealed competitor oligonucleotide was added to the reaction.
After incubation of the mixture for 10 min on ice, 2.5 fmol
of probe was added and another incubation step followed for
20 min on ice. The DNA–protein complexes were subjected
to electrophoresis on 5% nondenaturing polyacrylamide gels,
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which were analysed using phosphorimaging instrument
(Molecular dynamics, GE Healthcare, Brondby, Denmark).
Cell Culture Transfections (Luciferase Reporter
Studies)
The LCT enhancer variants were generated by site-directed
mutagenesis in a two-step Polymerase Chain Reaction (PCR)
amplification of the pGL3 hLPH1085-13910C enhancer plas-
mid construct (Troelsen et al., 2003). First, the region was
amplified in two separate PCRs to generate a left fragment
containing a 5′ BamHI and a right fragment containing a 3′
SalI restriction site. The two fragments were then annealed to
create an overlap at the mutated position and amplified in a
second PCR to create the whole 450 bp fragment, containing
the restriction sites at both ends.
All enhancer fragments were TA-cloned into the pCR
2.1-TOPO plasmid (Invitrogen) and later inserted into pGL3
hLPH1085 with SalI and BamHI digest. The plasmids are
shown in Figure S1A. The sequences of all fragments were
verified by sequencing and the “ancestral” sequence is shown
in Figure S1B.
Caco-2 cells were grown to 80% confluence and plated
in 24-well plates the day before transient transfection, with
each well containing approximately 5 × 104 Caco-2 cells.
Each transfection experiment was carried out as four or eight
repeats. Cells were transfected with a total DNA amount
of 0.3 μg per well including 0.05 μg luciferase reporter
gene plasmid, 0.025 μg pCMV-lacZ plasmid (Promega) and
0.225μg pBluescript SK+ plasmid (Stratagene) in a 25μl vol-
ume containing 15 mMNaCl. A total of 25 μl of transfection
reagent containing 2 μM polyethyleneimine (PEI) in form of
Exgen 500 (22 kDa, Fermentas) in 10 mM NaCl solution or
PEI25 (25 kDa, Alfa Aesar) were added to the DNA mix.
After 2 and 9 days of transfection, the Caco-2 cells were
harvested and luciferase and β-galactosidase activity were
measured using the Dual-Light chemiluminescent reporter
gene assay (ABI) (Martin et al., 1996; Bronstein et al., 1997).
Luciferase activity was normalized against β-galactosidase ac-
tivity by calculating relative luciferase/β-galactosidase ratios
for each well, and difference between the transfection results
tested for statistical significance with a Student’s unpaired t-
test. Consistency of effect of the different variants in four
independent experiments was tested by a two-way (Analy-
sis of Variance) ANOVA (using GraphPad Prism software,
version 6.0d).
Haplotype Background of Variants
Eight of the 11 core haplotype markers, previously defined
by Hollox et al. (2001) were used to determine the most
likely LCT haplotype background: -958 C>T (rs 56064699),
-946 A>G, -943/42 TC> (rs148142676), -942 C>G,
-875 G>A (rs78205226), 678 A>G (rs562211644), 666
G>A (rs3754698), 5579 T>C (rs2278544). The (Simple Nu-
cleotide Polymorphism) SNPs 666 G>A, 5579 T>C were
genotyped using the KASP system (LGC Genomics). Typing
of the other haplotype defining markers was done by Sanger
sequencing, as was the LCT enhancer region. Haplotypes
were inferred using PHASE [version 2.1.1 (Stephens et al.,
2001; Stephens & Donnelly, 2003; Stephens & Scheet, 2005)]
and results were inspected by eye.
Bioinformatic Analysis
Sequences for transcription factor binding sites were extracted
from binding motives stored in the TRANSFAC database
[TRANSFAC Professional version 12.1, BIOBASE Biologi-
cal Databases (Matys et al., 2006)]. To search for possible tran-
scription factors binding to the variant oligonucleotides, the
MATCH tool (Kel et al., 2003) of the TRANSFAC database
was used.
Human Samples
DNA samples used in this study were collected anonymously
with fully informed consent of the donors, with permissions
obtained from the relevant local authorities, under ethical
approvals for population genetics and LP (ULCH 99/0196,
01/0236 and UCL 2670/001).
Results
Transfections
Luciferase reporter gene expression of the different enhancer
variant constructs was measured in undifferentiated (2 days
after transfection) and differentiated Caco-2 cells [9 days af-
ter transfection, signs of differentiation visible as described
by Pinto et al. (1983)]. Constructs containing the LP alleles
-13910∗T and -14010∗C were included in the experiments
as controls since they were known to influence reporter gene
expression, at least in undifferentiated cells (Troelsen et al.,
2003; Tishkoff et al., 2007; Jensen et al., 2011).
The constructs containing the alleles -14009∗G and
-14011∗T show increased luciferase expression in both
undifferentiated and differentiated Caco-2 cells compared
to the ancestral construct that carries T at -14009 and C at
-14011 (Fig. 1). Over four independent experiments, each
consisting of four (or for differentiated cells in one case eight)
replicates, the average expression was increased approximately
1.4- and 1.5-fold in undifferentiated and 1.9- and 1.8-fold in
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Figure 1 Representative experiments showing luciferase reporter assays for LCT enhancer variants in
undifferentiated (undiff) and differentiated (diff) Caco-2 cells (after 2 and 9 days of transfection, respectively).
Luciferase activity of enhancer variant constructs are shown relative to the promoter only construct: (A) the
new variant alleles -14009∗G and -14011∗T located adjacent to -14010∗C, (B) the other two variants tested,
-13379∗C and -14028∗C. Luciferase activities (means ± SD, n = 4) were corrected for transfection
efficiency against ß-galactosidase and normalized to the expression of pGL3 hLPH1085 (promoter only).
Significant differences of luciferase activity compared to the ancestral variant were calculated using a
student’s t-test and are shown by ∗∗ (P < 0.01) and ∗ (P < 0.05). Maps and sequences of the plasmids are
shown in Figures S1A and B.
differentiated cells for -14009∗G and -14011∗C, respectively
compared with the ancestral sequence (see Figure S3). The
-13779∗C construct also showed a consistent increase in
reporter gene expression in both undifferentiated and differ-
entiated cells and, despite a high intraexperimental variance,
was highly significant across all experiments, as tested by
two-way ANOVA. In contrast to the other variant, alleles
-14028∗C did not show any evidence of influence on
enhancer activity.
Electrophoretic mobility shift essays (EMSAs)
To further investigate the influence of the four new variant
alleles on the LCT enhancer, electrophoretic mobility shift
essays (EMSAs) were performed to evaluate differences in
DNA binding properties to nuclear proteins extracted from
Caco-2 cells.
-14009T > G, -14010G > C and 14011C > T
To examine the effect of the -14009 T>G and -14011
C>T substitutions flanking the previously reported -14010
G>C functional variant, oligonucleotides were designed to
cover these positions, and were derived from the same length
of sequence used previously to study -14010 G>C ( Jensen
et al., 2011). A -14010C variant probe was thus also tested
for comparison in all experiments, as well as the probe with
the ancestral nucleotides at each position. Gel shift analysis
revealed similarities of all three derived probes but also major
differences (Fig. 2).
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Figure 2 Phosphorimages of gel shift assays of competition (A) and supershift experiments (B) for the -14011T, -14010C
and -14009G variant probes compared to the ancestral version. Competitors (Comp.) covering known binding sequences for
TFs and antibodies (Anti-) were used as indicated above the gel images, a nonspecific antibody was used as negative control.
Different probe–protein complexes were formed of which the upper ones (Complex 1) could be competed with Oct-1 and
HNF-1α competitors (A) and supershifted (B) with an Oct-1 antibody for all four probes, whereas the DNA–protein
complex formed with the -14009G probe (Complex 2) was not shifted. A slightly different binding pattern was seen for the
lower band for -14011T (Complex 3). Note that the ancestral version of the sequence used in these experiments is -14009T,
-14010G, -14011C (see Table S1).
In each case, the gel shifts show a low mobility band (Com-
plex 1), which is more intense for the -14011T and -14010C
variant probes than for -14009G or the ancestral probe, as
observed previously for -14010C. The sequence overlaps an
Oct-1 and HNF-1α binding site ( Jensen et al., 2011) and
the shifted band was reduced by both the HNF-1α and the
Oct-1 competitor, with slightly stronger competition with
HNF-1α (Fig. 2A). Binding of Oct-1 was confirmed with an
Oct-1 antibody resulting in a “super-shifted” protein–DNA
complex, generated with all variant probes (Fig. 2B), and no
shift but a slight inhibition of the complex formation was seen
with the HNF-1α antibody (not shown).
In the case of -14011T, there was also a slightly different
higher mobility DNA-protein complex (Complex 3). Bind-
ing of GATA-3 and 4 specifically to -14011T was predicted
bioinformatically. However, preliminary experimental results
with different GATA competitor oligonucleotides point to
a competition of both the ancestral as well as the derived
-14011 probes (data not shown).
The -14009G probe showed a pattern that differed more
dramatically from the three other probes tested at that locus,
in that a prominent additional DNA–protein complex was
formed (Complex 2 in Fig. 2), which was not affected by
the Oct-1 and HNF-1α competitors or antibodies. This sug-
gests that another protein in the intestinal nuclear extract is
specifically binding to the -14009G containing sequence.
Bioinformatic analyses predicted additional transcription
factors that might potentially bind to the derived sequence,
with G at position -14009, but not to the ancestral sequence.
These were members of the Ets transcription factor family, as
well as others for which the difference was less marked (NF-
kappaB, Pax, Pax4-8 and Pbx). Competitor oligonucleotides
were designed taking into account specific transcription factor
binding motifs found in TRANSFAC, or using information
about matching competitors available from the Affymetrix
EMSA kit (Table S1) and Figure 3 shows the EMSA ex-
periments with some of these competitors, comparing the
ancestral sequence and -14009G. The upper DNA–protein
complex formed with both the -14009G and the ancestral
probes (Complex 1) showed a very slight competition of
the binding for NF-kappaB, Pax, Pax4-8 and Pbx. How-
ever, -14009G complex 1 could be fully competed with the
ancestral sequence. The prominent lower band (Complex 2
in Fig. 3), obtained with the -14009G probe could not, on
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Figure 3 Phosphorimages of EMSAs of comparing the ancestral (A) and derived (B) variant probes
of the -14009T>C SNP. Competitors were used as indicated above the images. The specific
DNA–protein complex for -14009G (Complex 2) could not be competed with the corresponding
ancestral sequence competitor (Table S1) but was with competitor oligonucleotides of the Ets family.
the other hand, be competed with ancestral probe, confirm-
ing the specificity of the factor binding to the derived allele.
All Ets family oligonucleotides, c-Ets-1, Aff_ETS (1) and
Aff_ELK-1 competed with the -14009G specific band, but
the c-Ets-1 sequence had the greatest effect on the formation
of this complex. Interestingly, the upper band (Complex 1)
was also competed with the Aff_ELK-1 competitor in both
the ancestral and the -14009G probes (not shown).
The reciprocal experiments, using c-Ets-1 and Aff_ELK-1
as probes showed that the c-Ets-1 probe was more effectively
competed with -14009G than with the ancestral sequence,
whereas Aff-ELK-1 was competed with both competitor
sequences (not shown).
-13779G > C
Further gel shifts, examining the -13779 G>C SNP, re-
vealed a strong DNA–protein complex for both the ancestral
and derived variant probes that could be competed in a similar
way with the unlabelled probe containing either the ances-
tral or derived allele (Fig. 4). An HNF-4α binding site was
bioinformatically predicted for the derived allele but not the
ancestral sequence. However, complete competition of the
band was seen for both probes with the oligonucleotide con-
taining an HNF-4α binding site. This binding could be con-
firmed with the supershift of the complex formed with the
HNF-4α antibody also with no allele specific difference. Both
variant probes showed a slight competition with the Cdx-2
competitor and only the ancestral allele -13779G showed a
minor change in band intensity with the Oct-1 and HNF-1α
competitors (Fig. 4).
-14028T > C
Probes corresponding to both alleles of the -14028T>C
SNP bound strongly to proteins of the nuclear extract
(Fig. 5). This binding could in both cases be slightly competed
with unlabelled oligonucleotides containingOct-1 andHNF-
1α binding sites (not shown). However, the ancestral -14028T
probe was strongly competed with the Cdx-2 competitor se-
quence and specific binding of this protein to -14028T was
confirmed in supershift experiments. Binding to HNF-4α of
the derived -14028C probe but not the ancestral one was pre-
dicted bioinformatically and indeed, the DNA–protein bands
with the -14028C probe were decreased with the addition of
an HNF-4α competitor and a supershift with the HNF-4α
antibody confirmed that this transcription factor is binding to
the -14028C probe (Fig. 5).
Haplotype Backgrounds
In order to determine whether they were likely to have a com-
mon origin, and or whether there were other likely sequence
differences located within the region of the constructs, the
haplotype background of each of the derived alleles studied
here was inferred by genotyping of key markers (Hollox et al.,
2001) in as many of the samples as were readily available and
inferring the phase of the alleles using PHASE. They each
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Figure 4 Phosphorimages of EMSAs comparing the ancestral (A) and derived (B) variant probes of
the -13779 G>C SNP. Competitors with different binding sequences for TFs or an oligonucleotide
with a nonspecific sequence as well as an antibody (Anti) against HNF-4α were used as indicated
above the pictures. The specific DNA–protein complex (Complex 1) formed with both probes could
clearly be competed with the HNF-4α competitor and supershifted with the antibody to HNF-4α.
appear to occur on a specific and different haplotype back-
ground with the exception of -14011∗T, which occurred
most frequently on A (like -13910∗T and 13907∗G) but twice
on B (Table 1).
Discussion
In this paper we have found, using the classical approaches of
transfection and gel shift assays, new evidence for function in
vitro, of four relatively infrequent variants located in the LCT
enhancer.
It had previously been shown that -14010 G>C is lo-
cated in an Oct-1 binding site (-14021 to -14009 upstream of
LCT) and resides close to an HNF-1α binding site (-14007
to -13993; Figure S2) and the C substitution alters gene tran-
scription in vitro in Caco-2 cells (Jensen et al., 2011). Here we
study two further candidate functional variants, -14009 T>G
and -14011 C>T, adjacent to the well-studied -14010 G>C
variant, and show that they also have a clear effect on pro-
moter activity upregulation as assessed by transfection assays,
but notably are involved in different molecular interactions.
The results for the two other variants (-14028 T>C, -13779
G>C) were suggestive of function, -14028∗C showing a clear
change in transcription factor binding, but no obvious effect
in transfections, while -13779∗G showed greater effect in
transfections but less on transcription factor binding. Each
of the four variants arose on independent haplotypic back-
grounds and have different geographic distributions.
Our experiments on the three neighbouring variants show
that they have rather different effects on protein binding,
which nevertheless leads to the same transcriptional outcome
as the derived variant -14010∗C reported earlier. All three
variant probes and the corresponding ancestral sequence show
evidence of binding to Oct-1 but this is slightly stronger
for the -14010C and -14011T variant probes. Note that -
14009G on the other hand showed very clear binding to
yet another transcription factor with distinct electrophoretic
mobility. The bioinformatic analysis followed by the use of
target-designed competitors shows very good evidence that
this is a member of the Ets family, possibly c-Ets-1, even
though it has not yet been possible to confirm this in supershift
experiments using currently available antibodies.
Ets (E26 transformation-specific) factors are known to in-
teract with other proteins to regulate DNA binding or tran-
scription and to play an important role in the differentia-
tion, survival and proliferation of cells, including those of the
intestine (Sharrocks, 2001; Galang et al., 2004; Hsu et al.,
2004, Seth & Watson, 2005; Hollenhorst et al., 2011; Findlay
et al., 2013).
Annals of Human Genetics (2016) 80,307–318 313C© 2016 The Authors. Annals of Human Genetics published by University College London (UCL) and
John Wiley & Sons Ltd.
A. Liebert et al.
Figure 5 Phosphorimages of EMSAs comparing the ancestral and derived variant of the -14028 T>C SNP.
Competition experiments (Comp.) with unlabelled variant oligonucleotides for a specific competitor for Cdx-2 (A) or
HNF-4 α (B) indicate binding specificity of these TFs, which is shown further by supershift experiments with
antibodies (Anti) against Cdx-2 (A) and HNF-4 α (B). A nonspecific antibody was used as negative control (B). Note
that lanes were cut out of gel pictures but all remaining lanes are from the same gels. Bands were classified as
nonspecific binding when they were only present on some of the gels and were reduced or removed with competition
of nonspecific oligonucleotides.
The variant at -14028 T>C is located within a proposed
Cdx-2 binding site (Lewinsky et al., 2005). Here, we con-
firm this binding site experimentally since a clear supershift
could be seen for -14028T (ancestral probe) with a Cdx-2
antibody in EMSAs. We also found in vitro evidence for al-
teration of transcription factor binding at that locus since the
C substitution caused a loss of binding to Cdx-2 and gener-
ates a HNF-4α binding site. In view of the fact that there is
such a marked difference in the transcription factor binding,
and the strong prior evidence of high allelic expression, (see
Figure S4) the lack of effect in transfection experiments, at
least under the conditions tested, was surprising.
This led to consideration of the possible significance of
allelic differences in the haplotypic background of the re-
porter gene construct. The construct (Figure S1B) carries
the LCT promoter region from -1097 to -13, and there are
known polymorphic sites at positions -958, -946, -943/2,
-875, -678 and 559/552 and positions within that sequence
(Harvey et al., 1998; Hollox et al., 2001). The promoter
used for these constructs is the same throughout all the
experiments and carries the derived ∗T at -958 and the an-
cestral variants at the other positions (see Figure S1). Early
experiments showed that -958∗T disrupts binding to an
unknown transcription factor (Hollox et al. 1999), and a de-
creased expression in transfection experiments has also been
reported for -958∗T (Chitkara et al., 2001), suggesting that
this site plays a functional role. Interestingly, this sequence is
identical to that of the haplotypic background of the derived
-14028∗C and in fact different from that of the other derived
enhancer alleles tested here. Even though this effect is coun-
terintuitive, it seems likely that there are combinatorial effects
with SNPs at sites others than in the enhancer. The combined
effect of these different variants in vitro may well differ from
that in vivo. Another subtlety is that the -14133 to -14020
gene-regulatory region has been shown to decrease enhancer
function in reporter gene assays rather than increase it (Jensen
et al., 2011).
Although the reporter experiments to study -13779 G>C
gave high variance for reasons that were not clear, an increase
in expression was seen consistently. The probes were shown
to contain a HNF-4α binding site, with no allelic difference
but slight difference in Cdx-2 binding. The suggestive evi-
dence for a functional role of -13779∗C had been not very
strong since it had in fact previously been reported in one So-
mali individual who was diagnosed as a lactose mal-digester
(Ingram et al., 2009c). But its occurrence, in two South Indian
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Table 1 Occurrence of rare derived LCT enhancer alleles in populations clustered by country, and haplotype background defined as in
Hollox et al. (2001).
Variant
-14028 T>C -14011 C>T -14010 G>C -14009 T>G -13779 G>C
Geographic region rs759157971 rs4988233 rs145946881 rs869051967 rs527991977 n chromosomes
Europe/Asia
Belarus – 1 – – – 100
England 1 – – – – 140
Greece – 1 – – – 120
India – – – – 3 222
Italy – 1 – – – 258
Mongolia – 1 – – – 166
Ukraine – 1 – – – 74
Russia – 1 – – – 252
Sweden – 2 – – – 130
Middle East
Kuwait – – – 1 – 66
Iran – 1 – – – 154
Syria – – – – 1 140
Yemen – – 1 – 5 166
Africa
Ethiopia – – 1 7 – 370
Sudan – – – 25 – 204
Tanzania – – 12 – – 82
Haplotype B, G A, J; B, G P, W, Y X, m, n C, M, j, k
(inferred from n chromosomes tested) 2 7; 2 14 33 5
Sequence and haplotype data include samples of the African populations from Jones et al. (2015) and one previously published additional
individual carrying the -14028∗C allele (Poulter et al., 2003; Ingram, 2008) was used for haplotyping that allele. In the case of -13779∗C, the
samples from Yemen only had complete data for all the haplotype markers. Core LCT haplotype in bold is the most likely given the markers
tested. Previously published information on the populations carrying -13779∗C and -14011∗T in India is shown in Table S2.
pastoralist groups, the Toda and Yadava, at higher frequencies
than most of their nonpastoralist neighbours in Tamil Nadu,
initially prompted us to consider it as a potential functional
variant, although it was also found in one of the Tamil Nadu
Hunter-Gatherer groups, the Kurumba, at relatively high fre-
quency as well as in one hunter-gatherer group in Kerala
(Table S2, Gallego Romero et al., 2012). Curiously at least
one functional allele has also been found in African hunter-
gatherers (Ranciaro et al., 2014) and it is tempting to speculate
that these alleles may have originated in hunter-gatherer with
an early selection pressure operating through glycosides that
occur in plants, before spread into other groups and subse-
quent selection for milk drinking. Despite these uncertainties,
the combined results suggest that this variant is worth pursu-
ing further as a candidate locus.
The results presented here provide further strong sup-
port for the functional role of -14009∗G and indeed
more support for the functional role of this small up-
stream region, which also houses -14010∗C. The pattern of
distribution of -14009∗G in East African milk drinkers ( Jones
et al., 2015) is indicative of selection whereas this is not the
case for -14011∗T. Although -14011∗T would appear to be
functional and most of the alleles found so far are located
on the same or similar A haplotype background, they are
very rare, and scattered over many countries, including India
(Table S2), failing to show any noticeable impact of se-
lection. The two occurrences of -14028∗C both from the
United Kingdom appear to be on the same fairly extended B
haplotype background as each other (B), and interestingly
this variant has recently been reported in two other in-
stances (rs759157971), also both in the United Kingdom. The
-13779∗C allele is located on a C haplotype background and
is most prevalent in India, where it is clustered geographically
(Table S2).
The techniques used in this study provide suggestive evi-
dence of functional significance but may, of course, under-
estimate effects in vivo since the Caco-2 cell line expresses
only low levels of lactase and in some cases shows effects
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that are not important in vivo (Rousset, 1986). The role
of these variants could be pursued using cotransection ap-
proaches analogous to those on -13915 T>G and -13910
C>T described previously (Lewinsky et al., 2005; Enattah
et al., 2008), to show evidence of the interaction of the tran-
scription factors identified here with other factors involved in
lactase expression. However, techniques based on chromatin-
immunoprecipitation such ChIP-Seq (chromatin immuno-
precipitation coupled to high-throughput sequencing) give a
better insight to specific transcription factor DNA targets and
their networks in the intestine (e.g. reviewed in Olsen et al.,
2012) and could be useful to further examine the influence
of the LCT enhancer alleles on transcription factor binding
or influence of epigenetic modifications on LCT expression.
Ideally, these experiments should be conducted on isolated
intestinal enterocytes, though the chances of obtaining such
samples from individuals who carry rare variants are remote.
The recent work of Labrie et al. shows that the enhancer
region associated with -13910∗T escapes age-related DNA
methylation (Labrie et al., 2016). It seems likely that changes
in transcription factor binding, might be responsible for pre-
venting this methylation, and thus allowing continued adult
expression of LCT in carriers of this, and the other functional
variants. If the in vitro effects that we observe represent the in
vivo situation, one can imagine that the binding of somewhat
dynamic complexes of transcription factors is altered by the
nucleotide changes and that it is these changes that assist in
keeping the chromatin in an open and unmethylated state,
thus escaping epigenetic ageing.
This study illustrates the complexities of studying regu-
latory SNPs (rSNPs) but shows how a combination of ex-
perimental and bioinformatic approaches will be needed to
identify causal rSNPs in complex disease.
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